ACG Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
ACG Wealth's GILD Position: Q3 2022 in Review
ACG Wealth sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 1,168 shares — an estimated $72K sold.
ACG Wealth first reported a position in GILD in Q2 2013 and held it in 20 quarters. The position peaked at $4.69M in Q4 2015. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.
- ACG Wealth reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
- ACG Wealth sold 1,168 Gilead Sciences shares in Q3 2022, an estimated $72K.
- ACG Wealth first reported a position in Gilead Sciences in Q2 2013 and held it in 20 quarters.
- ACG Wealth's Gilead Sciences position peaked at $4.69M in Q4 2015.
- 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.
Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.